COMET BIOTECH AS

COMET BIOTECH AS is registered as a limited company in Østre Toten, Innlandet with organisation number 996171523. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2010. Registered share capital is NOK 100,000, divided into 100000 shares. The company's stated purpose is: “Utvikle og kommersialisere tjenester og teknologi innen gentoksikologisk testing.”. The most recent filed accounts, for the 2025 financial year, show NOK 25,000 in revenue and NOK 2,000 in operating profit.

Key figures · 2025

Revenue

NOK 25,000

Operating profit

NOK 2,000

Equity

NOK 168,000

Est. value

NOK 99,000

Financial health · 2025

Liquidity

15.03

Very good

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

93.3%

Very good

Equity as a share of total capital

Who owns COMET BIOTECH AS?

NORGENOTECH AS

100.0%

COMET BIOTECH AS

NOK 25,000 rev. · NOK 2,000 profit

COMET BIOTECH AS has 1 registered shareholder:

• NORGENOTECH AS 100.0%

All shareholders and roles →

Frequently asked questions about COMET BIOTECH AS

Who owns COMET BIOTECH AS?

NORGENOTECH AS is the largest registered owner, with 100.0%.

What is the revenue of COMET BIOTECH AS?

COMET BIOTECH AS had revenue of NOK 25,000 in 2025.

Who is the general manager of COMET BIOTECH AS?

Andrew Richard Sherman Collins is registered as general manager of COMET BIOTECH AS.

Where is COMET BIOTECH AS based?

COMET BIOTECH AS has its business address in Skreia.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.